<DOC>
	<DOC>NCT02386618</DOC>
	<brief_summary>Endoscopic mucosal resection (EMR) is considered to be a gold standard of therapy of colorectal lateral spreading tumors (LST) without significant risk for lymphatic spread. According to the investigators previous study, local residual neoplasia (LRN) after conventional endoscopic mucosal resection (EMR)occurs in up to 21% of cases. Endoscopic therapy of LRN was not sufficient in 53 % and has not been standardized yet.</brief_summary>
	<brief_title>Endoscopic Treatment for Local Residual Neoplasia</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>patients older than 18 years patients with local residual neoplasia in scar in three months after endoscopic mucosal resection for laterally spreading tumor (0IIa &gt; 10 mm) signed informed consent incomplete endoscopic mucosal resection previous therapy for local residual neoplasia difficult or impossible localization of postEMR scar</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>laterally spreading tumors</keyword>
	<keyword>endoscopic mucosal resestion</keyword>
	<keyword>local residual neoplasia</keyword>
</DOC>